HuidaGene Therapeutics

HuidaGene Therapeutics is a global clinical-stage biotechnology company focused on discovering, designing, and developing gene editing tools and gene therapies to rewrite the future of genomic medicine. Headquartered in Shanghai and New Jersey, HuidaGene is committed to meeting the needs of patients worldwide through a diverse range of therapeutic programs covering ophthalmology, neurology, neuromuscular, otology, and neuroscience. HuidaGene is dedicated to providing cutting-edge gene editing tools to deliver precise, safe, and effective one-time treatments for life-threatening conditions globally by addressing the root causes of diseases. We are committed to transforming the future of genomic editing medicine.